MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 596279 | Name: Iopydone

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Iopydone is an iodinated contrast dye.

Chemical Structure

Iopydone
Iopydone
CAS#5579-93-1

Theoretical Analysis

MedKoo Cat#: 596279

Name: Iopydone

CAS#: 5579-93-1

Chemical Formula: C5H3I2NO

Exact Mass: 346.8304

Molecular Weight: 346.89

Elemental Analysis: C, 17.31; H, 0.87; I, 73.17; N, 4.04; O, 4.61

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Iopydone; Hytrast; Iopydonum; NSC 135284; NSC-135284; NSC135284;
IUPAC/Chemical Name
3,5-diiodopyridin-4(1H)-one
InChi Key
FRPFEVLOFNAKBS-UHFFFAOYSA-N
InChi Code
InChI=1S/C5H3I2NO/c6-3-1-8-2-4(7)5(3)9/h1-2H,(H,8,9)
SMILES Code
O=C1C(I)=CNC=C1I
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 346.89 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Watanabe A, Saka H, Hasegawa Y, Shimokata K. [Survey of the state of bronchography in Japan]. Nihon Kyobu Shikkan Gakkai Zasshi. 1995 Feb;33(2):127-31. Japanese. PubMed PMID: 7731115. 2: Bétrémieux P, Tréguier C, Pladys P, Bourdinière J, Leclech G, Lefrancois C. Tracheobronchography and balloon dilatation in acquired neonatal tracheal stenosis. Arch Dis Child Fetal Neonatal Ed. 1995 Jan;72(1):F3-7. PubMed PMID: 7743281; PubMed Central PMCID: PMC2528410. 3: Ginai AZ, Ten Kate FJ, Ten Berg RG, Hoornstra K. Intraperitoneal toxicity of Hytrast: an experimental study. Br J Radiol. 1986 Nov;59(707):1079-82. PubMed PMID: 3790893. 4: Lehner K, Gullotta U. [Late complication following Hytrast bronchography. In vivo dilution as a cause of severe alveolarization?]. Prax Klin Pneumol. 1985 Apr;39(4):133-5. German. PubMed PMID: 4001085. 5: Ginai AZ, ten Kate FJ, ten Berg RG, Hoornstra K. Experimental evaluation of various available contrast agents for use in the upper gastrointestinal tract in case of suspected leakage. Effects on lungs. Br J Radiol. 1984 Oct;57(682):895-901. PubMed PMID: 6487960. 6: Gallo E, Romagnoli R, Marchetti M. [Technical and radiological methodology problems in the diagnosis of H-shaped esophagotracheal fistulae]. Radiol Med. 1980 Jan-Feb;66(1-2):61-2. Italian. PubMed PMID: 7455206. 7: DE BRUIN CD. [COMPLICATIONS FOLLOWING BRONCHOGRAPHY WITH HYTRAST]. Ned Tijdschr Geneeskd. 1965 Apr 17;109:758-60. Dutch. PubMed PMID: 14320734. 8: MISENER FJ, QUINLAN JJ, HILTZ JE. HYTRAST: A NEW CONTRAST MEDIUM FOR BRONCHOGRAPHY. Can Med Assoc J. 1965 Mar 20;92:607-10. PubMed PMID: 14264971; PubMed Central PMCID: PMC1928217. 9: GREENBERG SD, HALLMAN GL Jr, SPJUT HJ. PULMONARY TISSUE REACTION FOLLOWING HYTRAST BRONCHOGRAMS. Ann Otol Rhinol Laryngol. 1964 Dec;73:1095-107. PubMed PMID: 14239528. 10: LIGHT JP, OSTER WF. STUDY OF THE CLINICAL AND PATHOLOGIC REACTION TO THE BRONCHOGRAPHIC AGENT HYTRAST. Am J Roentgenol Radium Ther Nucl Med. 1964 Sep;92:615-22. PubMed PMID: 14217082. 11: LANG EK. A COMPARATIVE STUDY OF FEBRILE REACTIONS TO HYTRAST, AQUEOUS DIONOSIL, AND OILY DIONOSIL IN BRONCHOGRAPHY. Radiology. 1964 Sep;83:455-9. PubMed PMID: 14206632. 12: OKADA H, MATSUMURA K. [BRONCHOGRAPHY WITH A NEW SUSPENSION CONTRAST MEDIA (HYTRAST)]. Rinsho Hoshasen. 1964 Jun;9:451-5. Japanese. PubMed PMID: 14182156. 13: GREENBERG SD, HALLMAN GL Jr, SPJUT HJ. PULMONARY TISSUE REACTION FOLLOWING HYTRAST BRONCHOGRAMS. Trans Annu Meet Am Bronchoesophagol Assoc. 1964;44:106-19. PubMed PMID: 14270817. 14: LEROUX BT, DUNCAN JG. BRONCHOGRAPHY WITH HYTRAST. Thorax. 1964 Jan;19:37-43. PubMed PMID: 14105882; PubMed Central PMCID: PMC1018797. 15: LAMY P, SENOT R, ANTHOINE D, JACQUIN B, RFBEIX G, BERTHEAU JM. [VALUE OF A NEW CONTRAST MEDIUM IN BRONCHOLOGY, AG 41-123 (HYTRAST)]. Ann Med Nancy. 1963 Nov;2:1523-31. French. PubMed PMID: 14111516. 16: WEBB WR, FITTS CT. EVALUATION OF HYTRAST AS A BRONCHOGRAPHIC MEDIUM. Am Surg. 1963 Jul;29:491-5. PubMed PMID: 14046051. 17: RAYL DF, SPJUT HJ. Bronchographic crystalline-inclusion pneumonia due to Hytrast. Radiology. 1963 Apr;80:588-604. PubMed PMID: 13973325.